ClinicalTrials.gg
RecruitingNCT06260852Updated Mar 7, 2024

Identification of Minimum Focal Points in Vision Curve Formation

An observational study in Presbyopia, Pseudophakia and Cataract, sponsored by Democritus University of Thrace. Recruiting at 1 site in Greece. Open to participants aged 40 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-07.

Sponsored by Democritus University of Thrace · Observational

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 3 months ago, but the record still lists the study as recruiting.
  • Started Feb 2024; still recruiting 2 years 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
80
Ages
40 Years to 80 Years
Sex
All
01

Study summary

The primary objective of this study is to identify how many focal points and at which distances are necessary for reliable visual curve formation and area of the curve (AoC) calculation using mathematical models and comparing the results to measurements acquired from participants that underwent uncomplicated pseudophakic presbyopia surgery.

Read the detailed description

This is a prospective, non-inferiority trial. 80 participants that underwent uncomplicated pseudophakic presbyopia surgery with bilateral premium intraocular lenses (IOL) implantation will be recruited, and their postoperative Visual Curves (VAC) will be evaluated for nine distances (25, 28, 33, 40, 50, 60, 100, 200, 300 cm). Then, using polynomial and spline interpolation methods on the measured data, the aim is to generate a unique polynomial of degree ninc -1 that satisfies all data points.

02

Conditions studied

  • Presbyopia
  • Pseudophakia
  • Cataract
  • Refractive Errors

Keywords

  • pseudophakic presbyopic correction
  • premium monovision
  • trifocal diffractive intraocular lenses
  • extended depth of field intraocular lenses
03

In context

Presbyopia

336 studies on the registry are indexed under Presbyopia; 35 are open to participants now.

This study's planned enrollment of 80 is close to the median of 88 across 52 observational studies indexed under Presbyopia.

Browse Presbyopia studies →

Lead sponsor

Democritus University of Thrace is the lead sponsor of 70 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

participants that underwent uncomplicated pseudophakic presbyopia correction with bilateral premium intraocular lenses (IOL) implantation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age over 40,
  • previous bilateral premium cataract surgery,
  • best corrected visual acuity (BCVA) \< 0,2 logMAR

Exclusion criteria

Exclusion Criteria:

  • taking topical medication to reduce intraocular pressure (IOP),
  • macular diseases,
  • corneal diseases,
  • inability to understand the procedure,
  • postoperative astigmatism >1.50 diopters,
  • postoperative clouding of the posterior capsule
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Premium presbyopia surgery

    Participants that underwent uncomplicated pseudophakic presbyopia correction with bilateral premium intraocular lenses (IOL) implantation

    Diagnostic Test: Diagnostic Test: Visual Acuity Assessment

Interventions

  • Diagnostic testDiagnostic Test: Visual Acuity Assessment

    Uncorrected visual acuity for nine distances (25, 28, 33, 40, 50, 60, 100, 200, 300 cm) examination via a Democritus Digital Acuity \& Reading Test (DDART).

06

What researchers measure

Primary outcomes

  1. Visual curves interpolation

    Visual curves interpolation after visual acuity assessment in 9 focal points

    Time frame: 6 months

  2. Area of the curve (AOC) assessment

    Calculation of the AOC after visual curve interpolation

    Time frame: 6 months

  3. Visual acuity assessment

    Visual acuity assessment in 9 focal points using DDART chart

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Department of Ophthalmology, University Hospital of Alexandroupolis
    Alexandroupolis, Evros 68100, Greece
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06260852
Lead sponsor
Democritus University of Thrace
Responsible party
Georgios Labiris (Professor (Associate) of Democritus University of Thrace, Democritus University of Thrace) — Principal investigator
First posted
Feb 15, 2024
Start date
Feb 1, 2024
Primary completion
Aug 2024 (estimated)
Completion
Aug 2024 (estimated)
Last update
Mar 7, 2024

Study contacts

Georgios Labiris, MD, PhD
Contact
labiris@usa.net
00302551030405
Georgios Labiris, MD, PhD
study chair · Democritus University of Thrace

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion